DIALYSIS · CCN 742552

DaVita Fallbrook Dialysis

Houston, TX 77065

DialysisProfitDaVita
$2.6M
TOTAL REVENUE
11.6%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.6M
Total costs
$2.3M
Operating income (rev − costs)
$304K
Operating margin
11.6%
Total charges
$2.3M
Total treatments
6,280
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.3133—
Fistula Rate
DFC_FISTULA_RATE
63.852—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.4841—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
173.145—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.68——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2152—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19.3175—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
7.237—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
23.445—
Standardized ED Visits Ratio
DFC_SEDR
0.820—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
9.218—